首页> 外文期刊>Molecular therapy: the journal of the American Society of Gene Therapy >Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform
【24h】

Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform

机译:使用新型NF-κB/ NFAT报告细胞平台筛选嵌合抗原受体库筛选

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Chimeric antigen receptor (CAR)-T cell immunotherapy is under intense preclinical and clinical investigation, and it involves a rapidly increasing portfolio of novel target antigens and CAR designs. We established a platform that enables rapid and high-throughput CAR-screening campaigns with reporter cells derived from the T?cell lymphoma line Jurkat. Reporter cells were equipped with nuclear factor κB (NF-κB) and nuclear factor of activated T?cells (NFAT) reporter genes that generate a duplex output of enhanced CFP (ECFP) and EGFP, respectively. As a proof of concept, we modified reporter cells with CD19-specific and ROR1-specific CARs, and we detected high-level reporter signals that allowed distinguishing functional from non-functional CAR constructs. The reporter data were highly reproducible, and the time required for completing each testing campaign was substantially shorter with reporter cells (6?days) compared to primary CAR-T cells (21?days). We challenged the reporter platform to a large-scale screening campaign on a ROR1-CAR library, and we showed that reporter cells retrieved a functional CAR variant that was present with a frequency of only 6 in 1.05?× 106. The data illustrate the potential to implement this reporter platform into the preclinical development path of novel CAR-T cell products and to inform and accelerate the selection of lead CAR candidates for clinical translation.
机译:嵌合抗原受体(汽车)-T细胞免疫疗法处于激烈的临床前和临床调查,它涉及一种迅速增加的新型靶抗原和汽车设计的组合。我们建立了一个平台,使快速和高通量的汽车筛选活动能够与来自T?细胞淋巴瘤线Jurkat的报道细胞。记者细胞配备有核因子κB(NF-κB)和活性T的核因子,分别产生增强的CFP(ECFP)和EGFP的双工输出的细胞(NFAT)报告基因。作为概念证据,我们用CD19特异性和ROR1特定车修改了记者细胞,并且我们检测到允许从非功能性汽车构建体区分功能的高级报告信号。记者数据是高度可重复的,与原发性Car-T细胞(21个月)相比,完成每个测试活动所需的时间基本上短暂,报道细胞(6?天)短。我们将记者平台挑战到ROR1-CAR库中的大规模筛选活动,我们展示了报告细胞检索了一个函数的频率,其频率仅为1.05?×106。数据说明了潜在的潜力将本报告平台实施进入新型Car-T细胞产品的临床前开发路径,并为临床翻译提供铅载候选人的选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号